IMI is now making a "course correction" to ensure we focus on projects which inspire us to innovate.  Priorities at the moment include:

• Relocation of the business to capitalize on US economic recovery
• Analysis of data and key findings from the Patient Voice™ pilot project
• Maximize returns from our $3.3m investment in e-health R&D
• Sell existing intellectual property and software we own

If you would like to keep track of what we are working on and thinking about, I am sending in observations, related news stories and other stuff.  Soon found here.